Press releases in 2020
- Corona
An augmented immune response explains the adverse course of COVID-19 in patients with hypertension – could ACE inhibitors offer protection?
- Corona
The human helpers of SARS-CoV-2
Applying AI to cardiovascular medicine
Factors affecting healing: New Collaborative Research Center Dedicated to Bone Regeneration
Six BIH Charité scientists are among the most influential researchers worldwide in 2020
Personalized medicine to treat cystic fibrosis
Artificial intelligence for detecting strokes during sleep
When does it make sense to develop a new therapeutic agent? – A publication of recommendations for a successful translation in the journal Nature Reviews Drug Discovery
Pharma companies have long complained that findings from the laboratory are often not reproducible and that preclinical research does not provide a meaningful basis for developing new therapeutic agents. Scientists from the Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin, along with colleagues from the Fraunhofer Institute…
An atlas of the human pancreas
Tracking down the causes of heart attack - Misguided immune cells can contribute to vascular damage
- Corona
Fighting COVID-19 with AI: The prize winners of the fifth Future Medicine Science Match
Artificial intelligence for the medicine of tomorrow: Fifth Future Medicine Science Match to be held online
Georg Duda appointed BIH Chair for Engineering Regenerative Therapies
- Corona
How is the coronavirus pandemic changing health research? BIH discusses the topic at the World Health Summit
“Translation turns scientific findings into concrete help for people”
An in-depth atlas of the heart
National Center for Tumor Diseases in Berlin
Charité’s application, which involves close cooperation with the BIH and MDC, is successful
Tracing the genetic causes of type 2 diabetes
With the appointment of Claudia Langenberg to BIH Professor of Computational Medicine, the Berlin Institute of Health (BIH) and Charité–Universitätsmedizin Berlin are strengthening and expanding their leading role in data-driven medicine from September. Combining her expertise in genetic epidemiology and public health, she examines the molecular…
Atopic dermatitis app now covered by health insurer
Atopic dermatitis is an insidious disease that occurs primarily in children and young people and not only affects the skin, but can also become a major psychological burden. An app created by the Berlin-based medical device manufacturer Nia Health helps patients and parents better manage the disease and collects personalized data to develop…
New software detects disease-causing gene mutations
Improving European healthcare through cell-based interceptive medicine
Circular DNA – rings of genetic material
How does cancer develop and progress? A team led by pediatric oncologist Dr. Anton G. Henssen has set out to further improve our understanding of these processes. The researcher at the Experimental and Clinical Research Center (ECRC), a joint institution of Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine in…
A potential new target for immunotherapies in cancer
- Charité BIH InnovationDigital Labs
AI in the fight against cavities: BIH Digital Health Accelerator supports spin-off of the start-up dentalXrai
Christopher Baum chosen to head the BIH
Michael Potente to strengthen vascular research at BIH, Charité and MDC
HIV-1: The undercover agent
Research and clinical practice under one roof: BIH and Charité hold topping-out ceremony for ATIZ building
Joint Science Conference approves funding for NFDI4Health